Liu Yun, Xu Jie, Ge Chiyu, Zhang Tiantian, Chu Hongyi, Jing Yi, Xu Zhimeng, Xie Guoyong, Yuan Jun
Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Huaiyin Institute of Technology, Huai'an 223003, China; National & Local Joint Engineering Research Center for Mineral Salt Deep Utilization, Huaiyin Institute of Technology, Huai'an 223003, China.
Department of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China; School of Pharmacy, Jiangsu Food and Pharmaceutical Science College, Huai'an 223005, China.
Int J Biol Macromol. 2025 Apr;298:140071. doi: 10.1016/j.ijbiomac.2025.140071. Epub 2025 Jan 18.
To investigate the physicochemical properties, structural characteristics and in vitro activities of Shancigu polysaccharides to identify the authenticity of Shancigu, safeguard its medicinal value, and ensure the safety of its market distribution.
Eleven polysaccharides from different sources of Shancigu were obtained using water extraction and alcohol precipitation. Physicochemical properties were determined using colorimetry. Preliminary structural characterization was achieved using instrumental analyses, including infrared spectroscopy and gas chromatography. Anti-breast cancer and pro-inflammatory activities were compared using in vitro assays.
Shancigu polysaccharides mainly consist of pyranose sugars with α-type glycosidic bonds, including uronic acids, and sulfate groups. The most important monosaccharides are mannose and glucose. Glycosidic bonds were found to comprise (1 → 2) or (1 → 6) bond types. The molecular weight of Shancigu polysaccharides from different sources varied, with Cremastra appendiculata polysaccharides having the highest average molecular weight (352.713 kDa). Polysaccharides from the 11 different sources of Shancigu could all inhibit MCF-7 human breast cancer cells. Except for S2-S4, which had no significant effect, all other samples were able to promote the inflammatory response of RAW264.7.
This study provides a theoretical reference for further in-depth research and application of Shancigu polysaccharides. Based on the physicochemical properties, structural characteristics, and biological activities, this study can accurately and rapidly identify the authenticity of Shancigu. All results were consistent with the overall findings, providing a reliable scientific basis for the quality control, market regulation, and clinical application of Shancigu.
研究山慈菇多糖的理化性质、结构特征及体外活性,以鉴定山慈菇的真伪,维护其药用价值,确保其市场流通的安全性。
采用水提醇沉法从不同来源的山慈菇中获得11种多糖。采用比色法测定理化性质。通过红外光谱和气相色谱等仪器分析进行初步结构表征。采用体外试验比较抗乳腺癌和促炎活性。
山慈菇多糖主要由具有α型糖苷键的吡喃糖组成,包括糖醛酸和硫酸基团。最重要的单糖是甘露糖和葡萄糖。发现糖苷键包括(1→2)或(1→6)键型。不同来源的山慈菇多糖分子量不同,其中杜鹃兰多糖的平均分子量最高(352.713 kDa)。11种不同来源的山慈菇多糖均能抑制MCF-7人乳腺癌细胞。除S2-S4无显著作用外,其他样品均能促进RAW264.7的炎症反应。
本研究为山慈菇多糖的进一步深入研究和应用提供了理论参考。基于理化性质、结构特征和生物活性,本研究能够准确快速地鉴定山慈菇的真伪。所有结果与总体研究结果一致,为山慈菇的质量控制、市场监管和临床应用提供了可靠的科学依据。